Is Indo-Bangla Pharmaceuticals Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Indo-Bangla Pharmaceuticals Ltd (IBP.DS) is currently classified as HALAL as of February 2024. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Indo-Bangla Pharmaceuticals Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Indo-Bangla Pharmaceuticals Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Indo-Bangla Pharmaceuticals Ltd?

Muslim investors may consider investing in Indo-Bangla Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Indo-Bangla Pharmaceuticals Ltd classified as HALAL?

Musaffa determines the Shariah status of Indo-Bangla Pharmaceuticals Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Indo-Bangla Pharmaceuticals Ltd updated?

The Shariah compliance status of Indo-Bangla Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Indo-Bangla Pharmaceuticals Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Indo-Bangla Pharmaceuticals Ltd?

You can check the latest Shariah compliance status of Indo-Bangla Pharmaceuticals Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Indo-Bangla Pharmaceuticals Ltd IBP.DS

IBP.DS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: February 08, 2024

Report Source: 2023 Annual Report

Indo-Bangla Pharmaceuticals Ltd. Stock Analysis IBP.DS

Bangladesh Health Care Nano Cap Report: 2023 Annual

Indo-Bangla Pharmaceuticals Ltd. engages in the manufacture and sale of all kinds of medicine, medical preparations drugs, and chemicals. The firm is engaged in manufacturing and selling all kinds of medicines, medical preparations, drugs & chemicals (Human Health). The company manufactures approximately 450 generic drugs for over 5,300 registered brands. The company produces approximately 90 brands. The Company’s pharma portfolio encompasses various categories, including analgesics, respiratory, cardiovascular, central nervous system, dermatology, and gastrointestinal. Its products include Tablet I-Pedom 10mg, Tablet Indophylline 100mg, Tablet Sulbumol plus 4.0mg, Tablet Sulbumol 2.0mg, Tablet Albendox 400mg, Tablet Mebendox 100mg, Tablet I-Fol Plus, Tablet I-Fol, Tablet Indosin, Tablet Indo-Fila 100mg, Tablet Indomol Plus, Tablet Trialugel, and Tablet ICet 10mg.

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!

Indo-Bangla Pharmaceuticals Ltd IBP.DS

HALAL

Indo-Bangla Pharmaceuticals Ltd. Stock Analysis IBP.DS

Shariah Compliance Report

Disclaimer